SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against α2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases
J Immunol (2022) 208 (12): 2726–2737.
Currently there are no citedby results. Try again later.
